A higher incidence of colorectal cancer (CRC) is found in males compared to females.
Young women (18–44 years) with CRC have a better survival outcome compared to men of …

Colorectal cancer (CRC) is one of the most common causes of cancer morbidity in both
sexes but shows sex differences. First, sex-specific differences in tumor recurrence and …

Colorectal cancer (CRC) is the fourth commonest type of malignancy after breast, lung and
prostate in the USA and accounts for approximately 49,190 deaths annually in USA alone …

Background: Endogenous sex hormones may contribute to higher colorectal cancer
incidence rates in men compared with women, but despite an increased number of studies …

Although previous studies have suggested a potential role of sex hormones in the etiology of
colorectal cancer (CRC), no study has yet examined the associations between circulating …

Background/Aims: Little is known about the potential mechanism of action for androgen
receptor (AR) targeting treatment in estrogen receptor (ER)-negative breast cancer. This …

Previous epidemiological studies evaluated endogenous sex hormone levels and colorectal
cancer (CRC) risk have yielded inconsistent results. Also, it is unknown if consumption of …

Androgen receptor (AR) is expressed in normal murine and human kidneys of both genders,
but its physiologic role is uncertain. Several studies showed loss of AR in renal cell …

Colorectal cancer (CRC) is a common malignant tumor of the digestive system. Steroid 5α-
reductase type I (SRD5A1), as an important part of the steroid metabolism, converts …

According to its incidence patterns, colorectal cancer (CRC) tends to occur more frequently
in males than in females, and the evidence shows that CRC is a hormone-related tumor …